Search results
The 10 Best Performing Stocks So Far In 2024
Forbes· 4 days agoThe stocks have been on a tear with year-to-date gains ranging from 387% to more than a jaw-dropping 1,100% (as of June 14’s market close). The stock market has been buoyant in 2024, debunking ...
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor,...
Tehachapi News· 6 days agoG12D mutation is the most prevalent KRAS mutation detected in human cancers, and no G12D-targeted therapies have been approved yet.
Inhaled Insulin Could Help Folks With Type 1 Diabetes Avoid Needles
Fox Bangor· 1 day agoInhaled insulin could be a better option than injections or pumps for some patients with type 1...
‘My husband had a stent fitted on holiday – but Co-op won’t pay his £10k hospital bill’
The Telegraph via Yahoo News· 3 days agoSince our return, my husband has been treated by the NHS for obstructive jaundice complicated by ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by UBS Group
ETF DAILY NEWS· 5 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report) was downgraded by UBS Group from a “buy” rating to a “neutral” rating in a report issued on Thursday, Briefing.com reports. UBS Group ...
IgG4-Related Disease Affects Men More Often, More Severely
Medscape· 5 days agoA recent study highlighted sex-based differences in manifestations of IgG4-related disease.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target Cut to $10.00 by Analysts at Stifel Nicolaus
ETF DAILY NEWS· 6 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective reduced by Stifel Nicolaus from $32.00 to $10.00 in a research report report published on Tuesday morning, Benzinga ...
Wells Fargo & Company Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Equal Weight
ETF DAILY NEWS· 6 days agoWells Fargo & Company downgraded shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an overweight rating to an equal weight rating in a research report report published on Tuesday ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by Wedbush
ETF DAILY NEWS· 6 days agoWedbush downgraded shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday morning, MarketBeat ...
Zentalis Pharmaceuticals’ (ZNTL) “Hold” Rating Reaffirmed at Jefferies Financial Group
ETF DAILY NEWS· 6 days agoJefferies Financial Group restated their hold rating on shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) in a research report released on Tuesday morning, MarketBeat.com reports ...